Connecting with a supportive community is essential for people affected by muscular dystrophy to maintain both their emotional and physical…
Articles by Marisa Wexler, MS
Parent Project Muscular Dystrophy (PPMD) held its first conference in 1994, in Orlando, Florida. A year later, at its…
Capricor Therapeutics will soon meet with the U.S. Food and Drug Administration (FDA) to discuss plans for an application…
The Parent Project Muscular Dystrophy (PPMD) 30th annual conference kicks off today, offering families affected by Duchenne muscular…
The U.S. Food and Drug Administration (FDA) has expanded its approval of Elevidys (delandistrogene moxeparvovec-rokl), authorizing the one-time gene…
Duchenne muscular dystrophy (DMD) can make it harder to engage in social activities, and patients often experience grief and…
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to delpacibart etedesiran (del-desiran, previously called AOC…
Glucocorticoid use can help maintain breathing ability and arm function in adults with Duchenne muscular dystrophy (DMD), a new…
Treatment with an antioxidant supplement led to improvements in muscle strength and quality of life for people with facioscapulohumeral…
Diagnostic testing of individuals in India suspected of having limb-girdle muscular dystrophy (LGMD) revealed two novel mutations in the…